Close
CDMO Safety Testing 2026
Novotech

Recipharm bolsters senior leadership team with appointment of Joaquim Mascaro as Chief Financial Officer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal

Eli Lilly has entered into a multi-program collaboration with...

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...
- Advertisement -

Global contract development and manufacturing organisation (CDMO) Recipharm, has announced the appointment of Joaquim Mascaro as Chief Financial Officer.

Joaquim has worked for a range of organisations in the pharma, biotech and healthcare industries, across the US, Asia and Latin America. His experience in building and developing strong teams will be essential in supporting the organisation through its next phase of growth.

Marc Funk, CEO Recipharm said: โ€œI am delighted to welcome Joaquim to the Recipharm team as we continue to drive our business forward. Joaquimโ€™s impressive credentials and expertise will be a real asset to the senior leadership team and to the businessโ€.

Commenting on his appointment, Joaquim said: โ€œRecipharmโ€™s reputation and service offering in the industry is second to none. I am thrilled to be working for a leading top five CDMO on the quest for continuous growthโ€.

Joaquim joins on 3 April 2023 and replaces Michael Tyroller, who was interim CFO.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Latest stories

Related stories

Aragen Backs Renaissance Rare Disease Therapy Launch

Contract research, development, and manufacturing organization (CRDMO) Aragen has...

Eli Lilly and Haisco Pharmaceutical Enter $3Billion+ Deal

Eli Lilly has entered into a multi-program collaboration with...

Lilly Signs $1.26bn Sonefpeglutide Licensing Deal with Hanmi

Eli Lilly and Company and Hanmi Pharm have officially...

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has moved well beyond the research phase. In...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป